Article
A novel specific pyrosequencing method for genotyping FCGR3A rs396991 without coamplification of homologous gene FCGR3B.
Pharmacogenetics and genomics - 1 Nov 2013
van der Straaten Tahar, Martijn Richender, el Hajoui Toufik, Baak-Pablo Renee, Guchelaar Henk-Jan
Abstract excerpt
Monoclonal antibodies, such as rituximab, trastuzumab, and cetuximab, mediate immune response by binding to Fcγ receptors. The frequently occurring Phe158Val variant of the FCGR3A gene has increased binding affinity and consequently may affect immune response. Several pharmacogenetic association studies have genotyped this variant (FCGR3A rs396991), but with disconcordant results. In addition, in some of these...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
